• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮体 3-羟基丁酸通过受体 Gpr109a 介导的钙内流改善动脉粥样硬化。

Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx.

机构信息

School of Life Sciences Tsinghua University Beijing 100084 P. R. China.

Institute of Cell Biology Beijing Normal University Beijing 100875 P. R. China.

出版信息

Adv Sci (Weinh). 2021 Mar 1;8(9):2003410. doi: 10.1002/advs.202003410. eCollection 2021 May.

DOI:10.1002/advs.202003410
PMID:33977048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8097358/
Abstract

Atherosclerosis is a chronic inflammatory disease that can cause acute cardiovascular events. Activation of the NOD-like receptor family, pyrin domain containing protein 3 (NLRP3) inflammasome enhances atherogenesis, which links lipid metabolism to sterile inflammation. This study examines the impact of an endogenous metabolite, namely ketone body 3-hydroxybutyrate (3-HB), on a mouse model of atherosclerosis. It is found that daily oral administration of 3-HB can significantly ameliorate atherosclerosis. Mechanistically, 3-HB is found to reduce the M1 macrophage proportion and promote cholesterol efflux by acting on macrophages through its receptor G-protein-coupled receptor 109a (Gpr109a). 3-HB-Gpr109a signaling promotes extracellular calcium (Ca) influx. The elevation of intracellular Ca level reduces the release of Ca from the endothelium reticulum (ER) to mitochondria, thus inhibits ER stress triggered by ER Ca store depletion. As NLRP3 inflammasome can be activated by ER stress, 3-HB can inhibit the activation of NLRP3 inflammasome, which triggers the increase of M1 macrophage proportion and the inhibition of cholesterol efflux. It is concluded that daily nutritional supplementation of 3-HB attenuates atherosclerosis in mice.

摘要

动脉粥样硬化是一种慢性炎症性疾病,可导致急性心血管事件。NOD 样受体家族、含吡喃结构域蛋白 3(NLRP3)炎性小体的激活增强了动脉粥样硬化的发生,将脂质代谢与无菌炎症联系起来。本研究探讨了内源性代谢物酮体 3-羟基丁酸(3-HB)对动脉粥样硬化小鼠模型的影响。结果发现,每日口服 3-HB 可显著改善动脉粥样硬化。其作用机制是,3-HB 通过其受体 G 蛋白偶联受体 109a(Gpr109a)作用于巨噬细胞,降低 M1 巨噬细胞比例并促进胆固醇流出。3-HB-Gpr109a 信号促进细胞外钙(Ca)内流。细胞内 Ca 水平的升高减少了内质网(ER)中 Ca 从 ER 到线粒体的释放,从而抑制了 ER 钙库耗竭引发的 ER 应激。由于 NLRP3 炎性小体可被 ER 应激激活,因此 3-HB 可抑制 NLRP3 炎性小体的激活,从而增加 M1 巨噬细胞比例并抑制胆固醇流出。综上所述,每日营养补充 3-HB 可减轻小鼠的动脉粥样硬化。

相似文献

1
Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx.酮体 3-羟基丁酸通过受体 Gpr109a 介导的钙内流改善动脉粥样硬化。
Adv Sci (Weinh). 2021 Mar 1;8(9):2003410. doi: 10.1002/advs.202003410. eCollection 2021 May.
2
Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.GPR109A 受体的组织和配体依赖性信号差异:对抗动脉粥样硬化治疗潜力的影响。
Cell Signal. 2013 Oct;25(10):2003-16. doi: 10.1016/j.cellsig.2013.06.008. Epub 2013 Jun 14.
3
Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.肺炎衣原体劫持宿主自调控的 IL-1β 环促进泡沫细胞形成并加速动脉粥样硬化。
Cell Metab. 2018 Sep 4;28(3):432-448.e4. doi: 10.1016/j.cmet.2018.05.027. Epub 2018 Jun 21.
4
Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.德斯莫甾醇可抑制巨噬细胞炎症小体激活,防止血管炎症和动脉粥样硬化。
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47). doi: 10.1073/pnas.2107682118.
5
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis.NLRP3炎性小体:其调节作用及在动脉粥样硬化中的作用
J Cell Physiol. 2018 Mar;233(3):2116-2132. doi: 10.1002/jcp.25930. Epub 2017 May 23.
6
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.烟酸通过免疫细胞表达的受体 GPR109A 抑制小鼠动脉粥样硬化的进展。
J Clin Invest. 2011 Mar;121(3):1163-73. doi: 10.1172/JCI41651. Epub 2011 Feb 7.
7
Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.荷叶碱衍生物 R3 通过抑制 NLRP3 炎性小体相关炎症和调节胆固醇转运来减轻动脉粥样硬化。
FASEB J. 2020 Jan;34(1):1398-1411. doi: 10.1096/fj.201900903RRR. Epub 2019 Dec 1.
8
The ketone body β-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation.酮体 β-羟丁酸通过调节 NLRP3 炎性小体和破骨细胞分化缓解 CoCrMo 合金颗粒诱导的溶骨作用。
J Nanobiotechnology. 2022 Mar 9;20(1):120. doi: 10.1186/s12951-022-01320-0.
9
A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review.聚焦 NLRP3 炎性小体的潜在激活机制及其在动脉粥样硬化中的作用:综述。
Inflammation. 2020 Dec;43(6):2011-2020. doi: 10.1007/s10753-020-01290-1.
10
Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.炎症刺激脂肪组织和巨噬细胞中烟酸受体(GPR109A/HCA2)的表达。
J Lipid Res. 2014 Dec;55(12):2501-8. doi: 10.1194/jlr.M050955. Epub 2014 Oct 15.

引用本文的文献

1
A natural ultrasound-triggered nitric oxide booster for endothelial dysfunction therapy.一种用于内皮功能障碍治疗的天然超声触发一氧化氮增强剂。
Chem Sci. 2025 Aug 26. doi: 10.1039/d5sc04788a.
2
Ketone Bodies in Cardiovascular Disease: The Vasculature as a Therapeutic Target.心血管疾病中的酮体:以血管系统作为治疗靶点
JACC Basic Transl Sci. 2025 Jul 17;10(8):101328. doi: 10.1016/j.jacbts.2025.101328.
3
The role of ketone bodies in oxidized LDL-induced cell proliferation and lipid accumulation of macrophages.酮体在氧化型低密度脂蛋白诱导的巨噬细胞增殖和脂质积累中的作用。

本文引用的文献

1
Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells.生酮饮食改变肠道微生物组,导致肠道 Th17 细胞减少。
Cell. 2020 Jun 11;181(6):1263-1275.e16. doi: 10.1016/j.cell.2020.04.027. Epub 2020 May 20.
2
CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-catenin/TCF21 pathway.CXCL12 通过 CXCR4/GSK3β/β-连环蛋白/TCF21 通路下调 ABCA1 表达促进动脉粥样硬化。
J Lipid Res. 2019 Dec;60(12):2020-2033. doi: 10.1194/jlr.RA119000100. Epub 2019 Oct 29.
3
Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.
Int J Exp Pathol. 2025 Jul;106(4):e70002. doi: 10.1111/iep.70002.
4
Unveiling the Anti-Aging Potential of 3HB: Lifespan Extension and Cellular Senescence Delay.揭示3-羟基丁酸(3HB)的抗衰老潜力:延长寿命和延缓细胞衰老
Nutrients. 2025 May 12;17(10):1647. doi: 10.3390/nu17101647.
5
Isobutyrate Confers Resistance to Inflammatory Bowel Disease through Host-Microbiota Interactions in Pigs.异丁酸盐通过猪体内宿主-微生物群相互作用赋予对炎症性肠病的抗性。
Research (Wash D C). 2025 May 8;8:0673. doi: 10.34133/research.0673. eCollection 2025.
6
Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate.限时进食通过重塑肠道微生物群和代谢物3-羟基丁酸酯来预防脓毒症性肝损伤。
Gut Microbes. 2025 Dec;17(1):2486515. doi: 10.1080/19490976.2025.2486515. Epub 2025 Apr 13.
7
α-methyltryptophan-mediated protection against diabetic nephropathy in mice as studied with a metabolomics approach.用代谢组学方法研究α-甲基色氨酸对小鼠糖尿病肾病的保护作用。
Front Pharmacol. 2025 Jan 20;15:1463673. doi: 10.3389/fphar.2024.1463673. eCollection 2024.
8
Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart.酮体对心力衰竭运动不耐受的治疗潜力:超越心脏的视角
Cardiovasc Res. 2025 Apr 22;121(2):230-240. doi: 10.1093/cvr/cvaf004.
9
High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.高脂饮食、表观遗传学与动脉粥样硬化:一篇综述
Nutrients. 2024 Dec 31;17(1):127. doi: 10.3390/nu17010127.
10
β-Hydroxybutyrate Alleviates Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum Stress-Mediated Apoptosis via AMPK/Nrf2 Pathway.β-羟基丁酸通过AMPK/Nrf2途径抑制内质网应激介导的细胞凋亡减轻动脉粥样硬化钙化
Nutrients. 2024 Dec 30;17(1):111. doi: 10.3390/nu17010111.
酮症可改善多囊肾病中的肾囊肿生长。
Cell Metab. 2019 Dec 3;30(6):1007-1023.e5. doi: 10.1016/j.cmet.2019.09.012. Epub 2019 Oct 17.
4
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.短链脂肪酸(SCFAs)介导的肠道上皮和免疫调节及其对炎症性肠病的相关性。
Front Immunol. 2019 Mar 11;10:277. doi: 10.3389/fimmu.2019.00277. eCollection 2019.
5
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.治疗慢性心力衰竭患者酮体 3-羟丁酸的心血管效应。
Circulation. 2019 Apr 30;139(18):2129-2141. doi: 10.1161/CIRCULATIONAHA.118.036459.
6
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.动脉粥样硬化中的炎症及其解决:介质和治疗机会。
Nat Rev Cardiol. 2019 Jul;16(7):389-406. doi: 10.1038/s41569-019-0169-2.
7
Immunity and Inflammation in Atherosclerosis.动脉粥样硬化中的免疫与炎症。
Circ Res. 2019 Jan 18;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591.
8
Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension.盐反应代谢物 β-羟丁酸可减轻高血压。
Cell Rep. 2018 Oct 16;25(3):677-689.e4. doi: 10.1016/j.celrep.2018.09.058.
9
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.G 蛋白偶联受体在 NLRP3 炎性小体激活、调控和治疗中的作用。
Trends Pharmacol Sci. 2018 Sep;39(9):798-811. doi: 10.1016/j.tips.2018.07.002. Epub 2018 Jul 24.
10
Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.肺炎衣原体劫持宿主自调控的 IL-1β 环促进泡沫细胞形成并加速动脉粥样硬化。
Cell Metab. 2018 Sep 4;28(3):432-448.e4. doi: 10.1016/j.cmet.2018.05.027. Epub 2018 Jun 21.